Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice
We evaluated the effect of plaque-type psoriasis on health-related quality of life (HRQoL) of patients who received infliximab (IFX) in real-world clinical settings.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
11 February 2016
|
| In: |
Quality of life research
Year: 2016, Volume: 25, Issue: 8, Pages: 2031-2040 |
| ISSN: | 1573-2649 |
| DOI: | 10.1007/s11136-015-1224-z |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11136-015-1224-z
|
| Author Notes: | N.H. Shear, M. Hartmann, M.E. Toledo-Bahena, M. Gilbert, A. Katsambas, R. Yao, Z. Popmihajlov |
| Summary: | We evaluated the effect of plaque-type psoriasis on health-related quality of life (HRQoL) of patients who received infliximab (IFX) in real-world clinical settings. |
|---|---|
| Item Description: | Gesehen am 06.05.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1573-2649 |
| DOI: | 10.1007/s11136-015-1224-z |